JCS/JHRS 2021 Guideline Focused Update on Non-pharmacotherapy of Cardiac Arrhythmias

Overview

Journal J Arrhythm

Publisher Wiley

Date 2022 Feb 28

PMID 35222748

Authors

Akihiko Nogami

Takashi Kurita

Kengo Kusano

Masahiko Goya

Morio Shoda

Hiroshi Tada

Shigeto Naito

Teiichi Yamane

Masaomi Kimura

Tsuyoshi Shiga

Kyoko Soejima

Takashi Noda

Hiro Yamasaki

Yoshifusa Aizawa

Tohru Ohe

Takeshi Kimura

Shun Kohsaka

Hideo Mitamura

Affiliations

Soon will be listed here.

Citing Articles

Assessment of adverse events stratified by timing of leadless pacemaker implantation with cardiac implantable electronic devices extraction due to infection: A systematic review and meta-analysis.

Inoue N, Ito Y, Imaizumi T, Morikawa S, Murohara T J Arrhythm. 2025; 41(1):e13208.

PMID: 39817017 PMC: 11730721. DOI: 10.1002/joa3.13208.

Does Sinus Rhythm Restoration in Patients With Atrial Fibrillation Undergoing Pulmonary Vein Isolation Have Acute Hemodynamic Benefits?.

Komaki T, Mohri N, Ideishi A, Tashiro K, Koyanagi N, Miura S Cardiol Res. 2024; 15(4):298-308.

PMID: 39205957 PMC: 11349134. DOI: 10.14740/cr1692.

Editorial to "Safety and feasibility of atrial fibrillation ablation after left atrial appendage closure: A single-center experience of the left atrial appendage closure-first strategy".

Kondo Y, Ryuzaki S, Kobayashi Y J Arrhythm. 2024; 40(4):891-892.

PMID: 39139877 PMC: 11317718. DOI: 10.1002/joa3.13097.

Impact of left ventricular diastolic function and direct oral anticoagulant use for predicting embolic events in patients with heart failure and atrial fibrillation.

Yamamoto J, Hayama H, Enomoto Y, Yamamoto M, Hara H, Hiroi Y J Arrhythm. 2024; 40(3):489-500.

PMID: 38939759 PMC: 11199849. DOI: 10.1002/joa3.13031.

A randomized controlled trial of the size-adjustable cryoballoon vs conventional cryoballoon for paroxysmal atrial fibrillation: The CONTRAST-CRYO II trial rationale and design.

Kawamura I, Miyazaki S, Inamura Y, Nitta J, Kobori A, Nakamura K Heart Rhythm O2. 2024; 5(5):301-306.

PMID: 38840770 PMC: 11148497. DOI: 10.1016/j.hroo.2024.04.006.

References

Huang W, Chen X, Su L, Wu S, Xia X, Vijayaraman P . A beginner's guide to permanent left bundle branch pacing. Heart Rhythm. 2019; 16(12):1791-1796. DOI: 10.1016/j.hrthm.2019.06.016. View

Zanon F, Ellenbogen K, Dandamudi G, Sharma P, Huang W, Lustgarten D . Permanent His-bundle pacing: a systematic literature review and meta-analysis. Europace. 2018; 20(11):1819-1826. DOI: 10.1093/europace/euy058. View

Sherazi S, McNitt S, Aktas M, Polonsky B, Shah A, Moss A . End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy. Pacing Clin Electrophysiol. 2013; 36(10):1273-9. DOI: 10.1111/pace.12188. View

El-Chami M, Clementy N, Garweg C, Omar R, Duray G, Gornick C . Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. JACC Clin Electrophysiol. 2019; 5(2):162-170. DOI: 10.1016/j.jacep.2018.12.008. View

Kirkpatrick J, Gottlieb M, Sehgal P, Patel R, Verdino R . Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol. 2011; 109(1):91-4. DOI: 10.1016/j.amjcard.2011.08.011. View

Kirchhof P, Blank B, Calvert M, Camm A, Chlouverakis G, Diener H . Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J. 2017; 190:12-18. PMC: 5546174. DOI: 10.1016/j.ahj.2017.04.015. View

Waks J, Passman R, Matos J, Reynolds M, Thosani A, Mela T . Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation.... Heart Rhythm. 2018; 15(11):1601-1607. DOI: 10.1016/j.hrthm.2018.06.027. View

Hunter R, Berriman T, Diab I, Kamdar R, Richmond L, Baker V . A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014; 7(1):31-8. DOI: 10.1161/CIRCEP.113.000806. View

Enomoto Y, Gadiyaram V, Gianni C, Horton R, Trivedi C, Mohanty S . Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device. Heart Rhythm. 2016; 14(1):19-24. DOI: 10.1016/j.hrthm.2016.10.020. View

10.

Al-Khatib S, Thomas L, Wallentin L, Lopes R, Gersh B, Garcia D . Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J. 2013; 34(31):2464-71. DOI: 10.1093/eurheartj/eht135. View

11.

Arnold A, Shun-Shin M, Keene D, Howard J, Sohaib S, Wright I . His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block. J Am Coll Cardiol. 2018; 72(24):3112-3122. PMC: 6290113. DOI: 10.1016/j.jacc.2018.09.073. View

12.

Rhodes L, Walsh E, GAMBLE W, Triedman J, Saul J . Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol. 1995; 18(5 Pt 1):1005-16. DOI: 10.1111/j.1540-8159.1995.tb04741.x. View

13.

Sharma P, Dandamudi G, Herweg B, Wilson D, Singh R, Naperkowski A . Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: A multicenter experience. Heart Rhythm. 2017; 15(3):413-420. DOI: 10.1016/j.hrthm.2017.10.014. View

14.

Sharma A, Dhoot J, Wang J, Jones P, Gupta S, Wimmer A . Outcomes following cryoballoon ablation for atrial fibrillation guided by pressure waveform monitoring without the routine use of pulmonary venography. J Interv Card Electrophysiol. 2017; 49(1):75-82. DOI: 10.1007/s10840-017-0249-3. View

15.

Steinwender C, Khelae S, Garweg C, Chan J, Ritter P, Johansen J . Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results From the MARVEL 2 Study. JACC Clin Electrophysiol. 2019; 6(1):94-106. DOI: 10.1016/j.jacep.2019.10.017. View

16.

Asmarats L, Rodes-Cabau J . Percutaneous Left Atrial Appendage Closure: Current Devices and Clinical Outcomes. Circ Cardiovasc Interv. 2017; 10(11). DOI: 10.1161/CIRCINTERVENTIONS.117.005359. View

17.

Soejima K, Edmonson J, Ellingson M, Herberg B, Wiklund C, Zhao J . Safety evaluation of a leadless transcatheter pacemaker for magnetic resonance imaging use. Heart Rhythm. 2016; 13(10):2056-63. DOI: 10.1016/j.hrthm.2016.06.032. View

18.

Crossley G, Padeletti L, Zweibel S, Hudnall J, Zhang Y, Boriani G . Reactive atrial-based antitachycardia pacing therapy reduces atrial tachyarrhythmias. Pacing Clin Electrophysiol. 2019; 42(7):970-979. PMC: 6850031. DOI: 10.1111/pace.13696. View

19.

Aminian A, Lalmand J, Tzikas A, Budts W, Benit E, Kefer J . Embolization of left atrial appendage closure devices: A systematic review of cases reported with the watchman device and the amplatzer cardiac plug. Catheter Cardiovasc Interv. 2015; 86(1):128-35. DOI: 10.1002/ccd.25891. View

20.

Okishige K, Yamauchi Y, Hanaki Y, Inoue K, Tanaka N, Yamaji H . Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation. J Thromb Thrombolysis. 2019; 47(4):487-494. DOI: 10.1007/s11239-019-01835-8. View